Antiparasitics are a group of drugs used to treat illnesses caused by parasites like nematodes, cestodes, trematodes, and infectious protozoa.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V3882 | Tafenoquine | 106635-80-7 | Tafenoquine (formerly known as SB252263-AAB;WR-238605; WR238605;Brand name Krintafel) is an 8-aminoquinoline analog and oral drug developed by GlaxoSmithKline that has been investigated and approved in 2018 as a potential treatment for malaria, as well as for malaria prevention. |
|
V3883 | Tafenoquine succinate | 106635-81-8 | Tafenoquine succinate (formerly WR-238605; Krintafel), thesuccinate salt of tafenoquine, is an orally bioactive 8-aminoquinoline based anti-malarial drug approved for the treatment and prophylaxis of malaria. |
|
V54055 | TbPTR1 inhibitor 2 | 17557-67-4 | TbPTR1 inhibitor 2 (Compound 3a) is a PTR1 enzyme inhibitor (antagonist) with IC50s of 34.2 and 32.9 μM for TbPTR1 and LmPTR1, respectively. |
|
V78960 | TCMDC-125431 | TCMDC-125431 is a novel inhibitor of Plasmodium calcium dynamics but minimally inhibits heme crystallization. | |
|
V54105 | TCMDC-125457 | 872113-12-7 | TCMDC-125457 is effective in inducing calcium redistribution but minimally inhibits heme crystallization. |
|
V21096 | TCMDC-135051 hydrochloride | 2705545-47-5 | TCMDC-135051 HCl is a selective inhibitor of the protein kinase PfCLK3 with low off-target toxicity. |
|
V76281 | TCMDC-135051 TFA | 2571578-55-5 | TCMDC-135051 TFA is a selective inhibitor of the protein kinase PfCLK3 with low off-target toxicity. |
|
V81547 | TCMDC-136230 | TCMDC-136230 is a novel inhibitor of Plasmodium calcium dynamics but minimally inhibits heme crystallization. | |
|
V85708 | TDI-8304 | 2307262-96-8 | |
|
V53130 | Teclozan (WIN 13146) | 5560-78-1 | Teclozan (WIN 13146) is an antiprotozoal agent belonging to the benzylamine analogues class. |
|
V54051 | Tectol | 24449-39-6 | Tectol, extracted from Lippia sidoides, has significant inhibitory effects on human leukemia cell lines HL60 and CEM. |
|
V52669 | Temephos-d12 (Temefos-d12) | 1219795-39-7 | Temephos-d12 is the deuterium labelled form of Temephos. |
|
V53008 | Tiliquinol (TSC 130828) | 5541-67-3 | Tiliquinol (NSC 130828) is a non-absorbable antiamoebic agent. |
|
V54123 | Topoisomerase II inhibitor 16 | 2403729-27-9 | Topoisomerase II inhibitor 16 (compound CT3) is a selective, orally bioactive, BBB (blood-brain barrier) permeable (penetrable), and irreversible inhibitor of trypanosomal topoisomerase II that stabilizes double-stranded DNA: enzymatic cleavage Complex. |
|
V35173 | TPE-MI (Tetraphenylethene maleimide) | 1245606-71-6 | TPE-MI (Tetraphenylethene maleimide) is intrinsically non-fluorescent until conjugated to thiols via maleimide. |
|
V53019 | trans-4-Methylcyclohexanamine (trans-4-methylcyclohexanamine) | 2523-55-9 | trans-4-Methylcyclohexanamine is an intermediate that may be utilized in the development of T. cruzi enzyme inhibitors. |
|
V84785 | trans-Cinnamic anhydride | 21947-71-7 | |
|
V56275 | trans-Clopenthixol dihydrochloride ((E)-Clopenthixol dihydrochloride) | 58045-22-0 | trans-Clopenthixol ((E)-Clopenthixol) diHClide is an antibiotic and has no neuroleptic effects. |
|
V76289 | trans-Permethrin (trans-NRDC-143) | 61949-77-7 | trans-Permethrin is the trans configuration of Permethrin. |
|
V54040 | Triclabendazole sulfoxide (TCBZ-SO) | 100648-13-3 | Triclabendazole sulfoxide (TCBZ-SO) is the major plasma metabolite of triclabendazole and has antiparasitic effects. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
